Lluis Castells

Summary

Affiliation: Hospital Universitari Vall d'Hebron
Country: Spain

Publications

  1. ncbi request reprint Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients
    Lluis Castells
    Liver Unit, Department of Medicine, Hospital Universitari Vail d Hebron, Barcelona, Spain
    Antivir Ther 11:1061-70. 2006
  2. ncbi request reprint Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
    Lluis Castells
    Liver Unit, Internal Medicine Department, Hospital General Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Ps Vall d Hebron 119 129, 08035 Barcelona, Spain
    J Hepatol 43:53-9. 2005
  3. ncbi request reprint [Viral hepatitides infections in transplant recipients]
    Lluis Castells
    Servicio de Medicina Interna Hepatología, Hospital General Universitario Vall d Hebron, Universidad Autonoma, Barcelona, Espana
    Enferm Infecc Microbiol Clin 24:118-28. 2006
  4. doi request reprint Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis
    Gonzalo Sapisochin
    Department of HBP Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Ann Surg Oncol 20:1194-202. 2013
  5. ncbi request reprint Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?
    Isabel Campos-Varela
    Liver Unit, Department of Internal Medicine, Hospital Universitario Vall d Hebron, Barcelona, Spain
    Ann Hepatol 10:180-7. 2011
  6. doi request reprint Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients
    Isabel Campos-Varela
    Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d Hebron, Institut de Recerca VHIR, Universitat Autonoma de Barcelona, Barcelona, Spain
    Transplantation 93:450-3. 2012
  7. ncbi request reprint Liver transplantation in HIV-HCV coinfected patients: a case-control study
    Lluis Castells
    Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Transplantation 83:354-8. 2007
  8. ncbi request reprint Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation
    Carlos Margarit
    Liver Transplantation Unit, Department of Surgery, Hospital Vall Hebron, Universidad Autonoma, Barcelona, Spain
    Liver Transpl 11:1242-51. 2005
  9. ncbi request reprint Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients
    Isabel Campos-Varela
    Liver Unit, Department of Internal Medicine, Universitat Autònoma de Barcelona Barcelona, Spain
    Ann Hepatol 13:219-30. 2014
  10. doi request reprint Imaging of hepatitis C virus infection in liver grafts after liver transplantation
    Laura Mensa
    Liver Unit, Hospital Clinic, IDIBAPS, CIBERehd, Barcelona, Spain
    J Hepatol 59:271-8. 2013

Collaborators

Detail Information

Publications24

  1. ncbi request reprint Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients
    Lluis Castells
    Liver Unit, Department of Medicine, Hospital Universitari Vail d Hebron, Barcelona, Spain
    Antivir Ther 11:1061-70. 2006
    ..To investigate the efficacy of early antiviral treatment for hepatitis C virus (HCV) recurrence in HIV/HCV-coinfected patients undergoing liver transplantation for end-stage liver disease...
  2. ncbi request reprint Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
    Lluis Castells
    Liver Unit, Internal Medicine Department, Hospital General Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Ps Vall d Hebron 119 129, 08035 Barcelona, Spain
    J Hepatol 43:53-9. 2005
    ..The efficacy and safety of treatment with pegylated interferon alpha-2b (Peg-Intron, 1.5 microg/kg) and ribavirin (400-800 mg) in the acute phase of recurrent HCV after LT is presented...
  3. ncbi request reprint [Viral hepatitides infections in transplant recipients]
    Lluis Castells
    Servicio de Medicina Interna Hepatología, Hospital General Universitario Vall d Hebron, Universidad Autonoma, Barcelona, Espana
    Enferm Infecc Microbiol Clin 24:118-28. 2006
    ..The best patient selection (in non-replicative phase), the indefinite use of hyperimmune anti-hepatitis B immunoglobulin and the use of the new antiviral drugs have made possible a significant improvement in graft and patient survival...
  4. doi request reprint Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis
    Gonzalo Sapisochin
    Department of HBP Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Ann Surg Oncol 20:1194-202. 2013
    ..We aimed to assess the long-term outcome of cirrhotic patients with single HCC ≤5 cm treated either with LR or LT on an intention-to-treat basis...
  5. ncbi request reprint Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?
    Isabel Campos-Varela
    Liver Unit, Department of Internal Medicine, Hospital Universitario Vall d Hebron, Barcelona, Spain
    Ann Hepatol 10:180-7. 2011
    ..The risk of recurrent hepatitis B virus (HBV) infection and prognosis of liver transplantation in patients with HBV has dramatically changed with the use of prophylaxis including hepatitis B immune globulin (HBIg) and antiviral agents...
  6. doi request reprint Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients
    Isabel Campos-Varela
    Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d Hebron, Institut de Recerca VHIR, Universitat Autonoma de Barcelona, Barcelona, Spain
    Transplantation 93:450-3. 2012
    ..This study evaluates the value of HCV-RNA determination at 12 weeks posttreatment (W+12) to predict SVR in liver transplant (LT) patients treated with pegylated interferon and ribavirin for recurrent HCV infection...
  7. ncbi request reprint Liver transplantation in HIV-HCV coinfected patients: a case-control study
    Lluis Castells
    Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Transplantation 83:354-8. 2007
    ..1%) of the control group and one patient (20%) of the HIV group presented a sustained virologic response (P=NS). Short- to midterm results of LT in HIV-HCV co-infected patients were excellent and similar to non-HIV patients...
  8. ncbi request reprint Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation
    Carlos Margarit
    Liver Transplantation Unit, Department of Surgery, Hospital Vall Hebron, Universidad Autonoma, Barcelona, Spain
    Liver Transpl 11:1242-51. 2005
    ..Salvage liver transplantation was performed in 16.2% of resected patients, with older age being the main contraindication. Outcome of salvage LT was similar to that of primary LT...
  9. ncbi request reprint Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients
    Isabel Campos-Varela
    Liver Unit, Department of Internal Medicine, Universitat Autònoma de Barcelona Barcelona, Spain
    Ann Hepatol 13:219-30. 2014
    ..In HCV-infected LT recipients, elevated bilirubin, older donor age, and failure to achieve SVR are independently associated with increased mortality. ..
  10. doi request reprint Imaging of hepatitis C virus infection in liver grafts after liver transplantation
    Laura Mensa
    Liver Unit, Hospital Clinic, IDIBAPS, CIBERehd, Barcelona, Spain
    J Hepatol 59:271-8. 2013
    ..The aim of our study was to characterize HCV antigens in liver grafts...
  11. ncbi request reprint A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C
    Carlos Margarit
    Liver Transplantation Unit, Department of General Surgery, Hospital Vall Hebron, Universidad Autonoma Barcelona, Barcelona, Spain
    Transpl Int 18:1336-45. 2005
    ..The main advantage of this regimen could be in HCV patients, as recurrence of hepatitis in the graft was less severe in the group of patients in whom steroids could be avoided completely...
  12. doi request reprint Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature
    Isabel Campos-Varela
    Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d Hebron, Institut de Recerca, Barcelona, Spain
    Liver Transpl 18:201-5. 2012
    ..Nonetheless, a formal assessment and prospective studies are needed to confidently indicate TIPS placement in this situation...
  13. ncbi request reprint Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: A cohort study
    Cristina Pérez-Cameo
    Liver Unit, Department of Internal Medicine, Vall d Hebron Hospital, Barcelona, Spain
    Liver Transpl 20:856-63. 2014
    ..08), being an LT recipient (OR = 3.47), a known etiology (OR = 2.08), and the presence of hepatocellular carcinoma (OR = 3.73). Liver Transpl 20:856-863, 2014. © 2014 AASLD. ..
  14. ncbi request reprint Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation
    Lluis Castells
    Liver Unit, Department of Biochemestry, Hospital General Vall d Hebron, Universitat Autonoma Barcelona, Barcelona, Spain
    Liver Transpl 8:892-900. 2002
    ....
  15. doi request reprint Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients
    Fernando Salvador
    Department of Infectious Diseases, Vall d Hebron University Hospital, Barcelona, Spain
    Liver Transpl 17:1304-8. 2011
    ..We also provide a review of the literature and emphasize donor screening and preventive measures...
  16. ncbi request reprint Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantation
    Victor Vargas
    Liver Transplant Unit, Hospital Vall d Hebron, Universidad Autonoma de Barcelona, Paseo Vall d Hebron 119, 08035, Barcelona, Spain
    Transpl Int 16:270-5. 2003
    ....
  17. ncbi request reprint Liver biopsy-related infection in liver transplant recipients: A current matter of concern?
    Cristina López Sánchez
    Departments of Infectious Diseases, Autonomous University of Barcelona, Barcelona, Spain
    Liver Transpl 20:552-6. 2014
    ....
  18. doi request reprint Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study
    Cristina Dopazo
    Department of HPB Surgery and Transplants, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Clin Transplant 26:E32-7. 2012
    ..Compliance with immunosuppressive therapy in liver transplant patients is critical to prevent acute organ rejection and/or late graft loss. Strategies to simplify the therapeutic regimen may improve adherence...
  19. ncbi request reprint Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure
    Jesús Quintero
    Pediatric Liver Transplant Unit, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Catalunya, Spain
    Liver Int 34:689-94. 2014
    ..The present study assessed the use the of indocyanine green plasma disappearance rate as a tool to predict the evolution of pediatric patients with acute liver failure...
  20. ncbi request reprint Liver transplantation for malignant diseases: selection and pattern of recurrence
    Carlos Margarit
    Liver Transplantation Unit, Department of Surgery, Hospital General Vall Hebron, Universidad Autonoma de Barcelona, 08035 Barcelona, Spain
    World J Surg 26:257-63. 2002
    ..Liver transplantation for other malignancies is admitted only in fibrolamellar hepatoma, hepatoblastoma, epithelioid hemangioendothelioma without extrahepatic disease, and in metastases from carcinoid tumors...
  21. ncbi request reprint Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area
    Xavier Xiol
    Liver Transplant Unit, Institut d Investigacio Biomedica de Bellvitge, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
    Liver Transpl 15:300-5. 2009
    ..Alternatively, the possibility of setting up a central laboratory in each organ procurement area should be considered...
  22. ncbi request reprint Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics
    Maria Varela
    Liver Unit, IMDM, Barcelona Clinic Liver Cancer BCLC Group, Hospital Clinic, CIBER HEPAD, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer, IDIBAPS, Barcelona, Spain
    J Hepatol 46:474-81. 2007
    ..This study assesses the safety, pharmacokinetics and efficacy of transarterial chemoembolization using drug eluting beads (DEB), an embolizing device that slowly releases chemotherapy to decrease systemic toxicity...
  23. ncbi request reprint Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial
    Antoni Mas
    Liver Unit, Institut de Malalties Digestives, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    J Hepatol 38:51-8. 2003
    ..The efficacy and safety of rifaximin in comparison with lactitol in the treatment of acute hepatic encephalopathy was assessed in a prospective randomized, double-blind, double-dummy, controlled trial...
  24. ncbi request reprint [Prognostic scores of cirrhosis]
    Isabel Campos-Varela
    Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Unidad de Hepatologia, Servicio de Medicina Interna, Hospital General Universitari Vall d Hebron, Barcelona, Espana
    Gastroenterol Hepatol 31:439-46. 2008
    ..and certain comorbidities in patients with cirrhosis (hepatic encephalopathy, hyponatremia, refractory ascites) are not well represented in the MELD...